<?xml version="1.0" encoding="UTF-8"?>
<p id="par0230">Based on the literature reviewed here, a total of 70 phytocompounds belonging to 8 classes from 62 different medicinal plants have been reported for anti-viral activities against coronaviruses, with focus on SARS-CoV (
 <xref rid="fig0030" ref-type="fig">Fig. 6</xref> ; 
 <xref rid="tbl0005" ref-type="table">Table 1</xref>). Most of these compounds have been used for treating other ailments in humans, revealing their multi-dimensional pharmacological properties. Analysis of the targets and mechanism of action of the phytocompounds indicates a broad spectrum of targets on both coronaviruses and the host receptors (
 <xref rid="fig0025" ref-type="fig">Fig. 5</xref>). These include blocking of ACE2 receptor binding by spike protein, inhibition of viral proteases, inhibition of viral replication, targeting coronavirus spike protein, and blocking viral entry into host (
 <xref rid="fig0025" ref-type="fig">Fig. 5</xref>; 
 <xref rid="tbl0005" ref-type="table">Table 1</xref>). With ongoing research for COVID-19 therapeutics, the list of anti-viral phytocompounds is certainly dynamic with more anticipated updates.
</p>
